You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-ALL

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-lymphoblastic Lymphoma, T-ALL Trial in Shanghai (CAR-T)

Recruiting
  • T-lymphoblastic Lymphoma
  • T-ALL
  • CAR-T
  • Shanghai, China
    Shanghai Ruijin Hospital
Nov 14, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

Not yet recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic T-Cell Lymphoma
  • CD1a-CAR T
  • Barcelona, Spain
  • +1 more
Jan 10, 2023

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

T Acute Lymphoblastic Leukemia, Early T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Italy (bone marrow

Recruiting
  • T Acute Lymphoblastic Leukemia
  • +3 more
  • bone marrow and/or peripheral blood samples withdrawal
  • Ancona, Italy
  • +9 more
Nov 24, 2022

T-ALL, T-NHL (Lymphoblastic) Trial in Germany (Nelarabine)

Completed
  • T-ALL, T-NHL (Lymphoblastic)
  • Stuttgart, Baden-Württemberg, Germany
  • +10 more
Aug 16, 2022

Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphoblastic
  • Leukemia
  • Houston, Texas
    MD Anderson Cancer Center
Jul 19, 2022

Leukemia, T Cell Trial in Beijing (CD7 CART)

Recruiting
  • Leukemia, T Cell
  • CD7 CART
  • Beijing, Hebei, China
    He bei Yan da Lu dao pei Hospital
May 24, 2022

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Jun 5, 2023

T-cell Acute Lymphoblastic Leukemia Trial in Beijing (CD5 CAR-T)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • CD5 CAR-T
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Oct 23, 2022

Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +3 more
  • RD13-02 cell infusion
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 6, 2023

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Hospital
Nov 22, 2022

AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

Recruiting
  • AML
  • +4 more
  • CD123-CAR T
  • +4 more
  • Memphis, Tennessee
  • +1 more
May 10, 2022

T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

Withdrawn
  • T-cell Acute Lymphoblastic Leukemia
  • T-lymphoblastic Lymphoma
  • Target CD7 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Nov 23, 2022

Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

Recruiting
  • Cytarabine+Thiotepa + Fludarabine + Busulfan
  • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • cytarabine+thiotepa+ fludarabine + busulfan
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022

T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Daratumumab / Hyaluronidase Injection
  • Chicago, Illinois
    Northwestern
Jun 17, 2022

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Australia, United States (WU-CART-007)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • WU-CART-007
  • Duarte, California
  • +7 more
Jun 22, 2022

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

T-Cell Acute Lymphoblastic Leukemia Trial in Shenzhen (Antigen-specific T cells CAR-T/CTL and DCvac)

Recruiting
  • T-Cell Acute Lymphoblastic Leukemia
  • Antigen-specific T cells CAR-T/CTL and DCvac
  • Shenzhen, Guangdong, China
    Shenzhen Geno-immune Medical Institute
Mar 14, 2022

T-ALL, Lymphoma, T-Cell Trial in Wuhan (SENL101)

Recruiting
  • T-ALL
  • Lymphoma, T-Cell
  • SENL101
  • Wuhan, Hubei, China
    Tongji Hospital
May 29, 2022

Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

Recruiting
  • Relapsed/Refractory, High Risk Hematologic Malignancies
  • T-ALL/Lymphoma
  • CD7CAR T cells
  • Langfang, Hebei, China
    Hebei Yanda Lu Daopei Hospital
Jun 30, 2022

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • UCAR-T Cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Dec 7, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • B-ALL
  • U-CAR-T Cells (LstCAR019)
  • Kunming, Yunnan, China
    Kunming Hope of Health Hospital
Nov 27, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (Metabolically Armed CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Metabolically Armed CD19 CAR-T cells
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 17, 2023